Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| SE1-H5226 | Human | Human Serpin A1 Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Alfalastin (LFB SA) | Approved | Lfb Biotechnologies Sas | Alfalastin | France | alpha 1-Antitrypsin Deficiency | Lfb Biotechnologies Sas | 2005-08-01 | alpha 1-Antitrypsin Deficiency | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Alpha-1 antitrypsin (Kalytera Therapeutics) | Clinical | Clalit Health Services | Details | ||
| VX-864 | VX-864 | Vertex Pharmaceuticals Incorporated | Details | ||
| VX-814 | VX-814 | Vertex Pharmaceuticals | Details | ||
| VX-634 | VX-634 | Phase 1 Clinical | Vertex Pharmaceuticals Incorporated | alpha 1-Antitrypsin Deficiency | Details |
| INBRX-101 | INBRX-101 | Phase 1 Clinical | Inhibrx | alpha 1-Antitrypsin Deficiency | Details |
| Belcesiran | DCR-A1AT | Phase 2 Clinical | Dicerna Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc | alpha 1-Antitrypsin Deficiency | Details |
| Fazirsiran | TAK-999; ADS-001; ARO-AAT | Phase 2 Clinical | Arrowhead Pharmaceuticals Inc, Takeda Pharmaceutical Co Ltd | alpha 1-Antitrypsin Deficiency | Details |
This web search service is supported by Google Inc.
A-Z
